Amylyx Pharmaceuticals Inc (AMLX) — Free Cash Flow Generation Index
Amylyx Pharmaceuticals Inc (AMLX) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $13.20 Million represents 1% of operating cash flow ($13.55 Million). Read Amylyx Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Amylyx Pharmaceuticals Inc across 1 annual periods. Explore Amylyx Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year Free Cash Flow Generation Index for Amylyx Pharmaceuticals Inc. For the full company profile including market capitalisation, see AMLX stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.90x | $10.68 Million | $11.92 Million | $1.24 Million | — |